Subsequent Events	3 Months Ended
Sep. 30, 2024
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 8. SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the unaudited condensed financial statements were issued. Based upon this review, other than as described below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed financial statements. On October 2, 2024, the Company, through a share capitalization, issued the Sponsor an additional 2,395,833 Class B ordinary shares, at which the Sponsor holds an aggregate of 9,583,333 Class B ordinary shares. All share and per share information has been retrospectively presented. On November 4, 2024, the Company consummated the Initial Public Offering of 25,000,000 Units at $10.00 per Unit, generating gross proceeds of $250,000,000. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 425,000 Private Placement Units at a price of $10.00 per Private Placement Unit in a private placement to the Sponsor, generating gross proceeds of $4,250,000. On November 4, 2024, in connection with the closing of the Initial Public Offering, the underwriters were entitled to a cash underwriting discount of $0.08 per Unit or $2,000,000 in the aggregate, $1,000,000 of which was paid at the closing of the Initial Public Offering, while the remaining balance of $1,000,000 is payable to the underwriters in equal amounts monthly starting on the 16th month following the closing of the Initial Public Offering until the 24th month following the closing of the Initial Public Offering. On November 4, 2024, the Company repaid all outstanding amounts under the Promissory Note.

Subsequent Events

3 Months Ended

Sep. 30, 2024

NOTE 8. SUBSEQUENT EVENTS

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the unaudited condensed financial statements were issued. Based upon this review, other than as described below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed financial statements.

On October 2, 2024, the Company, through a share capitalization, issued the Sponsor an additional 2,395,833 Class B ordinary shares, at which the Sponsor holds an aggregate of 9,583,333 Class B ordinary shares. All share and per share information has been retrospectively presented.

On November 4, 2024, the Company consummated the Initial Public Offering of 25,000,000 Units at $10.00 per Unit, generating gross proceeds of $250,000,000. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 425,000 Private Placement Units at a price of $10.00 per Private Placement Unit in a private placement to the Sponsor, generating gross proceeds of $4,250,000.

On November 4, 2024, in connection with the closing of the Initial Public Offering, the underwriters were entitled to a cash underwriting discount of $0.08 per Unit or $2,000,000 in the aggregate, $1,000,000 of which was paid at the closing of the Initial Public Offering, while the remaining balance of $1,000,000 is payable to the underwriters in equal amounts monthly starting on the 16th month following the closing of the Initial Public Offering until the 24th month following the closing of the Initial Public Offering.

On November 4, 2024, the Company repaid all outstanding amounts under the Promissory Note.